Lyric Bio, Inc. Closes $6.6 Million Seed Financing To Revolutionize Donor-Derived Therapeutics
Targeting up to 100x improvement in efficiency to enable 10x more affordable IVIg SAN CARLOS, Calif.–(BUSINESS WIRE)–Lyric Bio, Inc., (Lyric) a next-generation biomanufacturing startup developing human-tissue-based production systems for donor-derived therapeutics, has closed an oversubscribed…